Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | DRD4 | P21917 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17220125 | 1.00 | BCHE (0.44) | BCHEMAOBFUCA1CYP1A2CYP3A4 | |
| SCHEMBL5809623 | 0.85 | RECQL (0.42) | BCHEMAOBCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL5793687 | 0.79 | BCHE (0.40) | BCHEFUCA1 | |
| SCHEMBL3917960 | 0.78 | FUCA1 (0.43) | BCHEFUCA1CYP2D6DRD2 | |
| SCHEMBL4889413 | 0.78 | FUCA1 (0.43) | BCHEFUCA1CYP2D6DRD2 | |
| SCHEMBL3917962 | 0.78 | FUCA1 (0.43) | BCHEFUCA1CYP2D6DRD2 | |
| SCHEMBL17220043 | 0.78 | FUCA1 (0.43) | BCHEFUCA1CYP2D6DRD2 | |
| SCHEMBL19024339 | 0.78 | FUCA1 (0.43) | BCHEFUCA1CYP2D6DRD2 | |
| SCHEMBL17220186 | 0.78 | SIGMAR1 (0.52) | FUCA1DRD2 | |
| SCHEMBL17220185 | 0.78 | SIGMAR1 (0.52) | FUCA1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2616465-B1 | TRIAZINE-OXADIAZOLES | NOVARTIS AG (CH) | 2015-11-04 | — | — | EP | disclosed |